神経血管用機器/インターベンショナル神経学の世界市場予測（～2021年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Breakdown of primaries 23
2.2 OPPORTUNITY INDICATORS 23
2.2.1.1 Target disease prevalence 24
2.2.1.2 Rising geriatric population 25
2.2.1.3 Number of hospitals and surgical centers 27
2.2.1.4 Healthcare expenditure 28
2.2.1.5 Number of clinical researches 30
2.3 MARKET SIZE ESTIMATION 30
2.3.1 BOTTOM-UP APPROACH 31
2.3.2 TOP-DOWN APPROACH 32
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.5 RESEARCH ASSUMPTIONS 34
2.5.1 ASSUMPTIONS 34

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 40
4.1 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW 40
4.2 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET, BY REGION (2016 VS. 2021) 41
4.3 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY PRODUCT MARKET (2016 VS. 2021) 42
4.4 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY DISEASE PATHOLOGY, BY REGION (2016-2021) 43
4.5 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY (2016 VS. 2021) 44

5 MARKET OVERVIEW 45
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 KEY MARKET DRIVERS 47
5.2.1.1 Large target patient population 47
5.2.1.2 Ongoing product development and commercialization 48
5.2.1.3 Favorable medical reimbursements 49
5.2.1.4 Expansion of healthcare infrastructure across emerging markets 49
5.2.1.5 Growing market demand for effective neurovascular devices 50
5.2.2 KEY MARKET RESTRAINTS 51
5.2.2.1 Stringent regulatory scenario 51
5.2.2.2 Dearth of skilled neurosurgeons 52
5.2.3 KEY MARKET OPPORTUNITIES 52
5.2.3.1 Increasing number of research activities in the field of neurovascular therapies 52
5.2.3.2 Rising demand for minimally invasive neurosurgical procedures 53
5.3 ONGOING CLINICAL STUDIES 55
5.3.1 EMBOLIZATION COILING PROCEDURES 55
5.3.2 CAROTID ARTERY STENTING PROCEDURES 59
5.3.3 EMBOLIC PROTECTION PROCEDURES 66
5.3.4 FLOW DIVERSION PROCEDURES 68
5.3.5 SUPPORTING TECHNIQUES 70
5.3.6 NEUROTHROMBECTOMY PROCEDURES 71

6 INDUSTRY INSIGHTS 74
6.1 INTRODUCTION 74
6.2 SUPPLY CHAIN ANALYSIS 74
6.3 PORTER’S FIVE FORCES ANALYSIS 75
6.4 INDUSTRY TRENDS 76
6.4.1 INCREASING SURGEON’S AWARENESS RELATED TO BENEFITS OF STEREOTACTIC FRAMEWORK PROCEDURES IN NEUROSURGERIES 76
6.4.2 CHANNEL OPTIMIZATION 77
 

7 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY PRODUCT 78
7.1 INTRODUCTION 79
7.2 ANEURYSM COILING & EMBOLIZATION DEVICES 81
7.2.1 EMBOLIC COILS 84
7.2.1.1 Bare detachable coils 86
7.2.1.2 Coated detachable coils 87
7.2.2 FLOW DIVERSION DEVICES 88
7.2.3 LIQUID EMBOLIC AGENTS 89
7.3 CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 91
7.3.1 CAROTID ARTERY STENTS 93
7.3.2 EMBOLIC PROTECTION SYSTEMS 95
7.3.2.1 Distal filter devices 96
7.3.2.2 Balloon occlusion devices 97
7.4 SUPPORT DEVICES 99
7.4.1 MICROCATHETERS 101
7.4.2 MICROGUIDEWIRES 103
7.5 NEUROTHROMBECTOMY DEVICES 104
7.5.1 CLOT RETRIEVAL DEVICES 106
7.5.2 SUCTION AND ASPIRATION DEVICES 107
7.5.3 SNARES 109

8 GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY 110
8.1 INTRODUCTION 111
8.2 ISCHEMIC STROKES 112
8.3 CEREBRAL ANEURYSMS 114
8.4 ARTERIOVENOUS MALFORMATION AND FISTULAS 115
8.5 OTHER DISEASE PATHOLOGIES 116

9 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET,
BY REGION 117
9.1 INTRODUCTION 118
9.2 NORTH AMERICA 119
9.2.1.1 U.S. 124
9.2.1.2 Canada 124
 
9.3 EUROPE 125
9.3.1.1 Germany 130
9.3.1.2 France 131
9.3.1.3 U.K. 131
9.3.1.4 Rest of Europe 132
9.4 ASIA-PACIFIC 133
9.4.1.1 Japan 138
9.4.1.2 China 138
9.4.1.3 India 139
9.4.1.4 Rest of Asia-Pacific 140
9.5 REST OF THE WORLD 140

10 COMPETITIVE LANDSCAPE 144
10.1 OVERVIEW 144
10.2 MARKET SHARE ANALYSIS 145
10.3 COMPETITIVE SCENARIO 147
10.4 RECENT DEVELOPMENTS 148
10.4.1 PRODUCT LAUNCHES 148
10.4.2 STRATEGIC ACQUISITIONS 149
10.4.3 EXPANSIONS 150
10.4.4 AGREEMENTS AND COLLABORATIONS 151
10.4.5 OTHER DEVELOPMENTS 152

11 COMPANY PROFILES 153
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 INTRODUCTION 153
11.1.1 GEOGRAPHIC BENCHMARKING 153
11.2 STRYKER CORPORATION 154
11.3 MEDTRONIC PLC 157
11.4 JOHNSON & JOHNSON 162
11.5 TERUMO CORPORATION 165
11.6 PENUMBRA, INC. 169
11.7 BOSTON SCIENTIFIC CORPORATION 172
11.8 MICROPORT SCIENTIFIC CORPORATION 174
11.9 MERIT MEDICAL SYSTEMS, INC. 176
11.10 W.L. GORE & ASSOCIATES, INC. 179
11.11 ABBOTT LABORATORIES 180
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
 

12 APPENDIX 182
12.1 INSIGHTS OF INDUSTRY EXPERTS 182
12.2 DISCUSSION GUIDE 183
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 188
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 190
12.5 AVAILABLE CUSTOMIZATIONS 191
12.6 RELATED REPORTS 192
12.7 AUTHOR DETAILS 193